PubMed

Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation.

Crumpacker C, Heagy W, Bubley G, Monroe JE, Finberg R, Hussey S, Schnipper L, Lucey D, Lee TH, McLane MF, et al.

Ann Intern Med. 1987 Nov;107(5):664-74.PMID: 3662279 [PubMed - indexed for MEDLINE]Related articles

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Abrams DI, Kuno S, Wong R, Jeffords K, Nash M, Molaghan JB, Gorter R, Ueno R.

Ann Intern Med. 1989 Feb 1;110(3):183-8.PMID: 2463780 [PubMed - indexed for MEDLINE]Related articles

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.

Merigan TC, Skowron G, Bozzette SA, Richman D, Uttamchandani R, Fischl M, Schooley R, Hirsch M, Soo W, Pettinelli C, et al.

Ann Intern Med. 1989 Feb 1;110(3):189-94.PMID: 2536257 [PubMed - indexed for MEDLINE]Related articles

A trial with ribavirin in patients with AIDS or AIDS-related complex.

Crocchiolo P, Pristera R, Lazzarin A, Chemotti M, Froldi M, Palazzini E, Verani P, Orecchia A, Moroni M.

Boll Ist Sieroter Milan. 1989;68(2):185-90.PMID: 2491303 [PubMed - indexed for MEDLINE]Related articles

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al.

Ann Intern Med. 1990 May 15;112(10):727-37.PMID: 1970466 [PubMed - indexed for MEDLINE]Related articles

Multicenter clinical trial of oral ribavirin in symptomatic HIV-infected patients. The Ribavirin ARC Study Group.

[No authors listed]

J Acquir Immune Defic Syndr. 1993 Jan;6(1):32-41.PMID: 8417172 [PubMed - indexed for MEDLINE]Related articles

A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group.

Roberts RB, Dickinson GM, Heseltine PN, Leedom JM, Mansell PW, Rodriguez S, Johnson KM, Lubina JA, Makuch RW.

J Acquir Immune Defic Syndr. 1990;3(9):884-92. Erratum in: J Acquir Immune Defic Syndr 1991;4(4):450. PMID: 1974628 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.

Cooper DA, Pehrson PO, Pedersen C, Moroni M, Oksenhendler E, Rozenbaum W, Clumeck N, Faber V, Stille W, Hirschel B, et al.

AIDS. 1993 Feb;7(2):197-207.PMID: 8096703 [PubMed - indexed for MEDLINE]Related articles

A phase 1 study of ribavirin in human immunodeficiency virus-infected patients.

Roberts RB, Jurica K, Meyer WA 3rd, Paxton H, Makuch RW.

J Infect Dis. 1990 Sep;162(3):638-42.PMID: 2117625 [PubMed - indexed for MEDLINE]Related articles

Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections.

Miles SA, Wang HJ, Cortes E, Carden J, Marcus S, Mitsuyasu RT.

Ann Intern Med. 1990 Apr 15;112(8):582-9.PMID: 2109563 [PubMed - indexed for MEDLINE]Related articles

Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.

McKinney RE Jr, Pizzo PA, Scott GB, Parks WP, Maha MA, Lehrman SN, Riggs M, Eddy J, Lane BA, Eppes SC, et al.

J Pediatr. 1990 Apr;116(4):640-7.PMID: 2181102 [PubMed - indexed for MEDLINE]Related articles

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial.

Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, McCaffrey RP, Liebman HA.

N Engl J Med. 1990 May 10;322(19):1340-5.PMID: 2139174 [PubMed - indexed for MEDLINE]Related articles

The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study.

Kahn JO, Allan JD, Hodges TL, Kaplan LD, Arri CJ, Fitch HF, Izu AE, Mordenti J, Sherwin JE, Groopman JE, et al.

Ann Intern Med. 1990 Feb 15;112(4):254-61.PMID: 2297204 [PubMed - indexed for MEDLINE]Related articles

Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine.

Connolly KJ, Allan JD, Fitch H, Jackson-Pope L, McLaren C, Canetta R, Groopman JE.

Am J Med. 1991 Nov;91(5):471-8.PMID: 1659189 [PubMed - indexed for MEDLINE]Related articles

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial.

Lambert JS, Seidlin M, Reichman RC, Plank CS, Laverty M, Morse GD, Knupp C, McLaren C, Pettinelli C, Valentine FT, et al.

N Engl J Med. 1990 May 10;322(19):1333-40.PMID: 2139173 [PubMed - indexed for MEDLINE]Related articles

Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.

Stambuk D, Hawkins D, Gazzard BG.

J Infect. 1989 Jan;18 Suppl 1:41-51.PMID: 2492585 [PubMed - indexed for MEDLINE]Related articles

The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles.

Yarchoan R, Mitsuya H, Pluda JM, Marczyk KS, Thomas RV, Hartman NR, Brouwers P, Perno CF, Allain JP, Johns DG, et al.

Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S522-33.PMID: 1974724 [PubMed - indexed for MEDLINE]Related articles

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

Lane HC, Davey V, Kovacs JA, Feinberg J, Metcalf JA, Herpin B, Walker R, Deyton L, Davey RT Jr, Falloon J, et al.

Ann Intern Med. 1990 Jun 1;112(11):805-11.PMID: 1971503 [PubMed - indexed for MEDLINE]Related articles

Zidovudine treatment of AIDS and ARC in Denmark 1987.

Teglbjaerg LL, Mathiesen LR, Søeberg B, Nielsen L, Thorsen B, Buhl M, Pedersen C, Bonnevie O, Nielsen C, Vestergaard BF, et al.

Scand J Infect Dis. 1989;21(4):367-73.PMID: 2685984 [PubMed - indexed for MEDLINE]Related articles

Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)

Mulder JW, Cooper DA, Mathiesen L, Sandström E, Clumeck N, Gatell JM, French M, Donovan B, Gray F, Yeo JM, et al.

AIDS. 1994 Mar;8(3):313-21. Erratum in: AIDS 1994 Jun;8(6):following 859. PMID: 7913326 [PubMed - indexed for MEDLINE]Related articles